Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs by Altice, F.L., Kamarulzaman, A., Soriano, V.V., Schechter, M., Friedland, G.H.

Get full text

Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean by Bacon M, Pape JW, Cortes C, Padgett D, Gotuzzo E, Fink V, Ye I, Fang F, Masys DR, Schechter M

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy by Stöhr, W, Fidler, S, McClure, M, Weber, J, Cooper, D, Ramjee, G, Kaleebu, P, Tambussi, G, Schechter, M, Babiker, A, Phillips, R, Porter, K, Frater, J

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection by Hamlyn, E, Ewings, F, Porter, K, Cooper, D, Tambussi, G, Schechter, M, Pedersen, C, Okulicz, J, McClure, M, Babiker, A, Weber, J, Fidler, S, Phillips, R

Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. by Holodniy, M, Brown, S, Cameron, D, Kyriakides, T, Angus, B, Babiker, A, Singer, J, Owens, D, Anis, A, Goodall, R, Hudson, F, Piaseczny, M, Russo, J, Schechter, M, Deyton, L, Darbyshire, J

Features of patients with hereditary mixed polyposis syndrome caused by duplication of GREM1 and implications for screening and surveillance by Lieberman, S, Walsh, T, Schechter, M, Adar, T, Goldin, E, Beeri, R, Sharon, N, Baris, H, Ben Avi, L, Half, E, Lerer, I, Shirts, B, Pritchard, C, Tomlinson, I, King, M, Levy-Lahad, E, Peretz, T, Goldberg, Y

HIV-1 DNA predicts disease progression and post-treatment virological control. by Williams, J, Hurst, J, Stöhr, W, Robinson, N, Brown, H, Fisher, M, Kinloch, S, Cooper, D, Schechter, M, Tambussi, G, Fidler, S, Carrington, M, Babiker, A, Weber, J, Koelsch, K, Kelleher, A, Phillips, R, Frater, A

Short-course antiretroviral therapy in primary HIV infection. by Fidler, S, Porter, K, Ewings, F, Frater, J, Ramjee, G, Cooper, D, Rees, H, Fisher, M, Schechter, M, Kaleebu, P, Tambussi, G, Kinloch, S, Miro, J, Kelleher, A, McClure, M, Kaye, S, Gabriel, M, Phillips, R, Weber, J, Babiker, A

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption by Hurst, J, Hoffmann, M, Pace, M, Williams, J, Thornhill, J, Hamlyn, E, Meyerowitz, J, Willberg, C, Willberg, C, Koelsch, K, Robinson, N, Brown, H, Fisher, M, Kinloch, S, Cooper, D, Schechter, M, Tambussi, G, Fidler, S, Babiker, A, Weber, J, Kelleher, A, Phillips, R, Frater, A